BioNTech SE - ADR

-26.93 (-13.74%)
4:24:55 PM EDT: $170.99 +1.92 (+1.14%)
Other Pre-Announcement

Pfizer To Provide U.S. Government With Additional 10 Million Treatment Courses Of Its Covid-19 Oral Therapy

Published: 01/04/2022 16:56 GMT
BioNTech SE - ADR (BNTX) - Pfizer to Provide U.S. Government With an Additional 10 Million Treatment Courses of Its Oral Therapy to Help Combat Covid-19.
Pfizer Inc - Total of 20 Million Treatment Courses Will Be Delivered to U.S. Government in 2022.
Pfizer Inc - About 10 Million Treatment Courses Accelerated for Delivery by End of June.
Pfizer Inc - Raising Its Production Projections From 80 Million to 120 Million Courses of Treatment by End of 2022 for Paxlovid.
Pfizer Inc - Remaining 10 Million Courses of Paxlovid to Follow by End of September.